no code implementations • 5 Mar 2024 • Dong Chen, Gengzhuo Liu, Hongyan Du, JunJie Wee, Rui Wang, Jiahui Chen, Jana Shen, Guo-Wei Wei
As COVID-19 enters its fifth year, it continues to pose a significant global health threat, with the constantly mutating SARS-CoV-2 virus challenging drug effectiveness.
no code implementations • 3 Dec 2023 • Hongyan Du, Guo-Wei Wei, Tingjun Hou
This study embarked on an innovative and rigorous strategy to unearth potential drug repurposing candidates for opioid and cocaine addiction treatment, bridging the gap between transcriptomic data analysis and drug discovery.
no code implementations • 4 Aug 2023 • Haotian Zhang, Huifeng Zhao, Xujun Zhang, Qun Su, Hongyan Du, Chao Shen, Zhe Wang, Dan Li, Peichen Pan, Guangyong Chen, Yu Kang, Chang-Yu Hsieh, Tingjun Hou
Drug discovery is a highly complicated process, and it is unfeasible to fully commit it to the recently developed molecular generation methods.